A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9

G A Choudry, P A Hamilton Stewart, J A Double, M R Krul, B Naylor, G M Flannigan, T K Shah, J E Brown, R M Phillips

Research output: Contribution to journalArticlepeer-review

49 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9'. Together they form a unique fingerprint.

Medicine & Life Sciences